10129-052 NDC - GINGI-PAK MAX Z-TWIST NO 1 (DL EPINEPHRINE HCI)

Drug Information

Product NDC: 10129-052

Proprietary Name: GINGI-PAK MAX Z-TWIST NO 1

Non Proprietary Name: dl EPINEPHRINE HCI

Active Ingredient(s):
  • .197 mg/10mm EPINEPHRINE HYDROCHLORIDE


Administration Route(s): DENTAL; PERIODONTAL; SUBGINGIVAL

Dosage Form(s): SOLUTION

Pharmacy Class(es):
  • Adrenergic alpha-Agonists [MoA];
  • Adrenergic beta-Agonists [MoA];
  • Catecholamine [EPC];
  • Catecholamines [CS];
  • alpha-Adrenergic Agonist [EPC];
  • beta-Adrenergic Agonist [EPC]

Labeler Information

Labeler Name: Gingi-Pak a Division of the Belport
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date:5/24/1995

Package Information

No. Package Code Package Description Billing Unit
110129-052-012740 mm in 1 BOTTLE, PLASTIC (10129-052-01)

NDC Record

Field Name Field Value Definition
PRODUCT NDC10129-052The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEGINGI-PAK MAX Z-TWIST NO 1The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEdl EPINEPHRINE HCIThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTIONThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEDENTAL; PERIODONTAL; SUBGINGIVALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/24/1995This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED DRUG OTHERProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGingi-Pak a Division of the BelportName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEEPINEPHRINE HYDROCHLORIDEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH.197 
ACTIVE INGRED UNITmg/10mm 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Catecholamine [EPC], Catecholamines [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023